Business Description
Sunflower Pharmaceutical Group Co Ltd
ISIN : CNE100001WT7
Share Class Description:
SZSE:002737: Class ACompare
Compare
Traded in other countries / regions
002737.China IPO Date
2014-12-30Description
Sunflower Pharmaceutical Group Co Ltd is engaged in pharmaceutical manufacturing, marketing, and scientific research. The company's product profile include Honeysuckle, Weikangling Granules, Autumn pear moisturizing cream, Vitamin AD drops, Pediatric paracetamol granules, Jianweixiaoshi tablets, Pediatric Chai Gui Antipyretic Granules, Pediatric cough syrup, Kang Fu anti-inflammatory suppository, Xiangsha Yangwei Pills, and others.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 186.94 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 329.37 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 8.51 | |||||
| Beneish M-Score | 1.8 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 18.2 | |||||
| 3-Year EBITDA Growth Rate | 18.7 | |||||
| 3-Year EPS without NRI Growth Rate | 28.5 | |||||
| 3-Year FCF Growth Rate | -8.1 | |||||
| 3-Year Book Growth Rate | 14.4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.57 | |||||
| 9-Day RSI | 53.06 | |||||
| 14-Day RSI | 52.45 | |||||
| 6-1 Month Momentum % | -14.48 | |||||
| 12-1 Month Momentum % | -22.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4 | |||||
| Quick Ratio | 3.05 | |||||
| Cash Ratio | 2.24 | |||||
| Days Inventory | 150.87 | |||||
| Days Sales Outstanding | 13.85 | |||||
| Days Payable | 131.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 7.18 | |||||
| Dividend Payout Ratio | 1.01 | |||||
| Forward Dividend Yield % | 7.18 | |||||
| 5-Year Yield-on-Cost % | 8.69 | |||||
| Shareholder Yield % | 9.04 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 51.7 | |||||
| Operating Margin % | 23.24 | |||||
| Net Margin % | 19.29 | |||||
| FCF Margin % | -0.33 | |||||
| ROE % | 18.48 | |||||
| ROA % | 13.13 | |||||
| ROIC % | 35.1 | |||||
| ROC (Joel Greenblatt) % | 71.02 | |||||
| ROCE % | 20.49 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 14.41 | |||||
| Forward PE Ratio | 8.82 | |||||
| PE Ratio without NRI | 14.03 | |||||
| Shiller PE Ratio | 18.5 | |||||
| Price-to-Owner-Earnings | 17.79 | |||||
| PEG Ratio | 1.12 | |||||
| PS Ratio | 2.77 | |||||
| PB Ratio | 2.72 | |||||
| Price-to-Tangible-Book | 3.02 | |||||
| Price-to-Operating-Cash-Flow | 119.43 | |||||
| EV-to-EBIT | 9.47 | |||||
| EV-to-EBITDA | 9.47 | |||||
| EV-to-Revenue | 2.28 | |||||
| EV-to-FCF | -677.4 | |||||
| Price-to-Projected-FCF | 1.05 | |||||
| Price-to-DCF (Earnings Based) | 0.78 | |||||
| Price-to-Median-PS-Value | 1.18 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.05 | |||||
| Price-to-Graham-Number | 1.37 | |||||
| Price-to-Net-Current-Asset-Value | 4.94 | |||||
| Price-to-Net-Cash | 16.33 | |||||
| Earnings Yield (Greenblatt) % | 10.56 | |||||
| FCF Yield % | -0.12 | |||||
| Forward Rate of Return (Yacktman) % | 19.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sunflower Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 4,431.997 | ||
| EPS (TTM) (Â¥) | 1.45 | ||
| Beta | 0.5 | ||
| Volatility % | 34.36 | ||
| 14-Day RSI | 52.45 | ||
| 14-Day ATR (Â¥) | 0.44096 | ||
| 20-Day SMA (Â¥) | 20.8965 | ||
| 12-1 Month Momentum % | -22.29 | ||
| 52-Week Range (Â¥) | 18.22 - 30.79 | ||
| Shares Outstanding (Mil) | 584 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sunflower Pharmaceutical Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sunflower Pharmaceutical Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sunflower Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Sunflower Pharmaceutical Group Co Ltd(SZSE:002737)'s stock price today?
The current price of SZSE:002737 is ¥20.90. The 52 week high of SZSE:002737 is ¥30.79 and 52 week low is ¥18.22.
When is next earnings date of Sunflower Pharmaceutical Group Co Ltd(SZSE:002737)?
The next earnings date of Sunflower Pharmaceutical Group Co Ltd(SZSE:002737) is .
Does Sunflower Pharmaceutical Group Co Ltd(SZSE:002737) pay dividends? If so, how much?
The Dividend Yield %  of Sunflower Pharmaceutical Group Co Ltd(SZSE:002737) is 7.18% (As of Today), Highest Dividend Payout Ratio of Sunflower Pharmaceutical Group Co Ltd(SZSE:002737) was 1.24. The lowest was 0.2. And the median was 0.51. The  Forward Dividend Yield % of Sunflower Pharmaceutical Group Co Ltd(SZSE:002737) is 7.18%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers